RETENTION AND CONVERSION AGREEMENTRetention and Conversion Agreement • April 13th, 2011 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledApril 13th, 2011 Company Industry JurisdictionThis Agreement is entered into, effective as of September 28, 2009, by and between Northwest Biotherapeutics (“NWBT” or “the Company”), a Delaware corporation with its headquarters in Bethesda, Maryland, and Dr. Alton Boynton (“Dr. Boynton”), a resident of Kingston, Washington.
RETENTION AND CONVERSION AGREEMENTRetention and Conversion Agreement • November 23rd, 2009 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 23rd, 2009 Company Industry JurisdictionThis Agreement is entered into, effective as of September 28, 2009, by and between Northwest Biotherapeutics (“NWBT” or “the Company”), a Delaware corporation with its headquarters in Bethesda, Maryland, and Dr. Alton Boynton (“Dr. Boynton”), a resident of Kingston, Washington.